Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational studyKeiko Ihara, Tsubasa Takizawa, Seiya Ohtani et al.|The Journal of Headache and Pain|2023Cited by 82
Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosingKeiko Ihara, Tsubasa Takizawa, Seiya Ohtani et al.|Journal of the Neurological Sciences|2023Cited by 23
CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache societyTsubasa Takizawa, Jin Nakahara, Naoki Miyazaki et al.|The Journal of Headache and Pain|2024Cited by 17
Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective studySeiya Ohtani, Tsubasa Takizawa, Narumi Watanabe et al.|BMC Neurology|2023Cited by 15
Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in JapanKeiko Ihara, Tsubasa Takizawa, Nobuyuki Takahashi et al.|Internal Medicine|2024Cited by 6